A review of antithrombotic therapies in acute coronary syndrome: Should unfractionated heparin be replaced?

Formulary

Volumn 42, Issue 3, 2007, Pages 150-164

  Speredelozzi, Nicole ^a   Baroletti, Steven ^b   Fanikos, John ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ANTICOAGULANT AGENT; CREATINE KINASE MB; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; HEPARIN; HIRUDIN DERIVATIVE; HIRULOG; TROPONIN I;

ACUTE CORONARY SYNDROME; BLEEDING; BRAIN HEMORRHAGE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DRUG ADSORPTION; DRUG BINDING; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FIBRIN FORMATION; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTRAOCULAR HEMORRHAGE; PATIENT MONITORING; PERCUTANEOUS CORONARY INTERVENTION; RETROPERITONEAL HEMORRHAGE; REVIEW; RISK FACTOR; ST SEGMENT ELEVATION; THROMBOCYTOPENIA; THROMBUS;

EID: 34147220440     PISSN: 1082801X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)